Stay updated on Pembrolizumab SBRT in TKI mRCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab SBRT in TKI mRCC Clinical Trial page.

Latest updates to the Pembrolizumab SBRT in TKI mRCC Clinical Trial page
- ChecktodayChange DetectedRevision updated from v3.6.4 to v3.6.5. This appears to be a minor maintenance update with no observable changes to the study details or user-facing content.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, indicating a newer revision of the page content. This is a metadata update and does not alter the displayed study details.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, indicating a minor update to the page metadata. This change does not modify the study content or visible user-facing information.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page revision indicator was updated from v3.6.0 to v3.6.2, representing a minor system or editorial update and not a change to the study details or visible content.SummaryDifference0.1%

- Check58 days agoChange DetectedThe study record now indicates recruitment is closed (no longer looking for participants). New sections to help readers understand the study and how to join were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading formatting was updated alongside a revision update to v3.6.0.SummaryDifference0.5%

- Check65 days agoChange DetectedA new revision tag, v3.5.5, was added and the previous v3.5.4 tag removed, signaling an update to the study record.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab SBRT in TKI mRCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab SBRT in TKI mRCC Clinical Trial page.